Benzodiazepine Confirmation, Urine
Use
Confirmation of benzodiazepine exposure via urine metabolites when a presumptive positive screen exists (only orderable as a reflex following initial screening). Useful in confirming exposure to various benzodiazepines metabolites such as diazepam, nordiazepam, oxazepam, temazepam, alprazolam, lorazepam, triazolam, clonazepam, and flunitrazepam.
Special Instructions
Only orderable as a reflex; refers to FSHPU/Sedative Hypnotic Panel, Urine for primary ordering. Performing laboratory is Medtox Laboratories, Inc.
Limitations
Not orderable directly; prior screening required. Analytical performance and valid interpretive ranges are limited to the specified benzodiazepine analytes in urine; parent compounds often not detected in urine, metabolites are the targets.
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
LOINC Codes
- 16227-1
- 16228-9
- 16201-6
- 20559-1
- 59615-5
- 19328-4
- 17088-6
- 49876-6
- 51776-3
- 59590-0
- 20532-8
Result Turnaround Time
7-11 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
Not provided
Minimum Volume
Not provided
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 14 days |
| Frozen | 180 days |